Short Summary
The Delhi High Court decreed the suit filed by Alkem Laboratories Limited against Danish Health Care Pvt Ltd following an amicable settlement reached through court mediation. The dispute centered on the alleged infringement of Alkem’s registered trademark ‘ALDIGESIC’ in medicinal preparations. Under the terms of the settlement, the Defendants acknowledged Alkem's rights and agreed to cease using the infringing mark and similar trade dress, further agreeing to withdraw their own pending trademark application for 'ALGESIC'.
Detailed Summary
In the fiercely competitive pharmaceutical industry, a brand name is more than a label—it is a lifeline of trust between a company and its patients. When another player enters the market with a confusingly similar mark, the original owner faces not just lost sales, but a potential erosion of years of brand equity. The dispute between Alkem Laboratories Limited and Danish Health Care Pvt Ltd is a textbook example of how trademark conflicts in the pharma space can escalate quickly—and how the right legal strategy can turn a looming war into a clean, enforceable victory.
Alkem Laboratories Limited, an established pharmaceutical company, held the registered trademark 'ALDIGESIC' for medicinal preparations. This mark represented years of investment in branding, marketing, and patient trust. Danish Health Care Pvt Ltd, the opposing party, was allegedly using a mark and trade dress so similar to 'ALDIGESIC' that it risked creating confusion in the marketplace. Adding fuel to the fire, Danish Health Care had also filed its own trademark application for 'ALGESIC'—a mark that shared the distinctive 'GESIC' element with Alkem's registered brand. Faced with this encroachment, Alkem Laboratories approached the Delhi High Court seeking protection of its trademark rights.
Alkem Laboratories argued that its registered trademark 'ALDIGESIC' was being infringed by Danish Health Care's use of a confusingly similar mark and trade dress in the same pharmaceutical category. The core of Alkem's grievance was that the visual and phonetic similarity between the marks could mislead consumers and dilute the distinctiveness of its brand. Danish Health Care, on the other hand, had staked its claim through a pending trademark application for 'ALGESIC', suggesting an independent commercial identity. The legal friction centered on whether the shared 'GESIC' element was enough to cause confusion and whether Danish Health Care's actions constituted infringement of Alkem's existing registered rights.
Rather than dragging the dispute through a lengthy trial, the parties found common ground through court-mediated settlement discussions. Under the terms of the settlement, the Defendants formally acknowledged Alkem Laboratories' rights over the 'ALDIGESIC' trademark. Crucially, they agreed to completely cease using the infringing mark as well as any similar trade dress that could create confusion in the market. Danish Health Care also committed to withdrawing its pending trademark application for 'ALGESIC'—removing any future threat to Alkem's brand. With these terms agreed upon, the Delhi High Court was satisfied that the matter had been amicably resolved and proceeded to pass a decree in the original suit in favor of Alkem Laboratories, effectively giving the settlement the full force of a court order.
For founders and IP professionals, this case delivers a powerful lesson: court-supervised mediation is not a sign of weakness—it is a strategic tool that can deliver enforceable outcomes faster than a contested trial. If you discover a competitor using a confusingly similar mark, filing suit opens the door not only to a judicial ruling but also to a binding settlement that carries the weight of a court decree. Equally important, this case underscores the need to monitor not just active infringers, but also pending trademark applications that could mature into future threats. Proactive IP enforcement, paired with a willingness to negotiate under judicial supervision, can resolve even complex pharmaceutical trademark disputes with clarity and finality.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Delhi High Court - Orders. Understanding the court's reasoning in Alkem Laboratories Limited vs Danish Health Care Pvt Ltd & Anr. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
The North Face Apparel CorpvsController of Patents and Designs
The North Face Apparel Corp challenged the Controller of Patents' refusal of its patent application (No. 202147026139) titled 'Systems and Methods for End-to-End Article Management' before the Madras High Court under Section 117A of the Patents Act, 1970. The Controller had rejected the application citing lack of inventive step over prior art documents D21-D24. The Court held that the Controller erred by dissecting the claims into isolated elements rather than assessing the invention as a whole, and overlooked the use of spectrophotometer and invisible markers for tracking the manufacturing process, which were not disclosed in the cited prior art. The appeal was allowed and the Controller was directed to grant the patent.
Aventose Energy Private LimitedvsThe Assistant Controller of Patents & Designs, Patent Office Chennai
Aventose Energy Private Limited appealed under Section 117A of the Patents Act, 1970 against the refusal of its patent application (No. 202141019671) for a 'System and Method for Operating Automobiles with an Electric Drivetrain' featuring safe mode activation upon fault detection. The Madras High Court found that the Assistant Controller had contradicted the First Examination Report (which accepted novelty) by subsequently holding the invention lacked novelty without giving the applicant an opportunity to be heard. The court further held that the Controller improperly conflated novelty with inventive step under Section 2(1)(ja) and failed to properly analyze the claims against prior art documents D1–D4.
Apex Laboratories Pvt LtdvsElder Lifescience and Ambico Ayurvedic Health Care
Apex Laboratories Pvt Ltd, the prior adopter and registered proprietor of the trademark ZINCOVIT (TM No. 487453 in Class 5) since 1988, sought interim injunction against Elder Lifescience and Ambico Ayurvedic Health Care for using the deceptively similar mark NEO ZINCOVIT. The applicant also claimed copyright infringement of its registered artistic works (A-108878/2014) covering colour scheme, get-up, and layout. The Madras High Court was satisfied that the respondents were attempting to piggyback on the applicant's goodwill and granted interim injunctions on all three applications covering trademark infringement, copyright infringement, and passing off.
Radico Khaitan LimitedvsPicadilly Agro Industries Limited
This Special Leave Petition arose from a judgment dated 29-05-2026 in CS No. 8/2025 passed by the District Judge, Karnal, Haryana, concerning a trademark dispute over the marks 'Cashmere' and 'Kashmyr' used in relation to beer and vodka. The Supreme Court noted that a First Appeal (FAO-COM-11-2026) was already pending before the Division Bench of the Punjab and Haryana High Court, listed for 28.10.2026. The Court disposed of the SLP without adjudicating it on merits, requesting the High Court to pass an appropriate order regarding the ad interim injunction on the scheduled date.
Maharaja Agrasen Technical Educational Society (Regd.)vsMaharaja Agrasen Himalayan Garhwal University
The plaintiff, Maharaja Agrasen Technical Educational Society, filed a suit for permanent injunction against the defendant, Maharaja Agrasen Himalayan Garhwal University, alleging infringement and passing off regarding the use of the words 'Maharaja Agrasen' in the defendant's name. The Delhi High Court had previously granted a restraint order on 10.07.2026. During the pendency of the suit, the parties arrived at a settlement dated 14.09.2026, under which the defendant agreed to change its name through a statutory amendment while being permitted limited transitional use of its existing name. The court recorded the settlement, modified the interim order accordingly, and listed the matter for compliance reporting on 13.07.2027.
Varahi Diamonds And Finance LimitedvsSahil Vinay Mehra Trading As Mehra Sons Jewellers & Anr.
This is a commercial suit filed by Varahi Diamonds And Finance Limited against Sahil Vinay Mehra Trading As Mehra Sons Jewellers & Anr. before the Delhi High Court. The order is primarily procedural, dealing with the registration of the plaint, issuance of summons, directions for filing pleadings, and an interim injunction application. The matter was referred to mediation, with parties directed to appear before the Delhi High Court Mediation and Conciliation Centre.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.